B2M shows its highest regulation in myeloid cells across all subtypes, with the only exception of HER2+ breast cancers, where myeloid cells were also upregulated but slightly outcompeted by T-cells (ΔB2M,myel. Here, ERBB2 is linked to breast cancer.